4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
| Compound ID: | L309-1292 |
| Compound Name: | 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(oxolan-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
| Molecular Weight: | 448.5 |
| Molecular Formula: | C20 H24 N4 O6 S |
| Smiles: | C1CC(C1)c1nc(CN2C(COc3ccc(cc23)S(NCC2CCCO2)(=O)=O)=O)no1 |
| Stereo: | RACEMIC MIXTURE |
| logP: | 1.4534 |
| logD: | 1.4534 |
| logSw: | -2.6083 |
| Hydrogen bond acceptors count: | 12 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 107.672 |
| InChI Key: | XUZQHHDVLPPOBE-CQSZACIVSA-N |